Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutation.

Dohogne B, Arif-Tiwari H, Bracamonte E, Babiker HM. "Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutation." Anticancer Drugs. 2021;32(3):337-343.